中华医学杂志（英文版）2017，Vol.130Issue(8)：914-919,6.DOI:10.4103/0366-6999.204107
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study
Jing Zhou 1Yue-Ying Liu 2Jiang-Shan Lian 1Li-Fang Pan 1Jian-Le Yang 1Jian-Rong Huang1
作者信息
- 1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China
- 2. Department of Infectious Disease, The First People's Hospital of Yongkang, Jinhua, Zhejiang 321300, China
- 折叠
摘要
关键词
Drug Resistance/Hepatitis B/Tenofovir/Therapy/SafetyKey words
Drug Resistance/Hepatitis B/Tenofovir/Therapy/Safety引用本文复制引用
Jing Zhou,Yue-Ying Liu,Jiang-Shan Lian,Li-Fang Pan,Jian-Le Yang,Jian-Rong Huang..Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study[J].中华医学杂志（英文版）,2017,130(8):914-919,6.
